Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 16806
Country/Region: Zimbabwe
Year: 2016
Main Partner: Zimbabwe Association of Church-Related Hospitals
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $1,204,772 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $22,964
Care: Pediatric Care and Support (PDCS) $22,964
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Testing: HIV Testing and Counseling (HVCT) $322,078
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $42,720
Treatment: Adult Treatment (HTXS) $725,983
Treatment: Pediatric Treatment (PDTX) $68,063
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: <1 2017 126
HTS_TST Age/sex: <1 2017 63
HTS_TST Age/sex: 1-9 2017 504
HTS_TST Age/sex: 1-9 2017 377
HTS_TST Age/sex: 10-14 Female 2017 146
HTS_TST Age/sex: 10-14 Female 2017 97
HTS_TST Age/sex: 10-14 Male 2017 106
HTS_TST Age/sex: 10-14 Male 2017 92
HTS_TST Age/sex: 15-19 Female 2017 1,094
HTS_TST Age/sex: 15-19 Female 2017 577
HTS_TST Age/sex: 15-19 Male 2017 792
HTS_TST Age/sex: 15-19 Male 2017 555
HTS_TST Age/sex: 20-24 Female 2017 438
HTS_TST Age/sex: 20-24 Female 2017 722
HTS_TST Age/sex: 20-24 Male 2017 317
HTS_TST Age/sex: 20-24 Male 2017 693
HTS_TST Age/sex: 25-49 Female 2017 1,313
HTS_TST Age/sex: 25-49 Female 2017 1,300
HTS_TST Age/sex: 25-49 Male 2017 951
HTS_TST Age/sex: 25-49 Male 2017 1,248
HTS_TST Age/sex: 50+ Female 2017 292
HTS_TST Age/sex: 50+ Female 2017 289
HTS_TST Age/sex: 50+ Male 2017 211
HTS_TST Age/sex: 50+ Male 2017 277
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 5,733
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 4,545
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 5,284
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 4,314
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 28,697
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 26,426
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 24,732
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 23,266
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 64,446
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 58,551
HTS_TST Service Delivery Point (Facility): Index testing 2017 1,290
HTS_TST Service Delivery Point (Facility): Index testing 2017 8,245
HTS_TST Service Delivery Point (Facility): Inpatient 2017 3,947
HTS_TST Service Delivery Point (Facility): Inpatient 2017 615
HTS_TST Service Delivery Point (Facility): Other PITC 2017 3,623
HTS_TST Service Delivery Point (Facility): Other PITC 2017 46,098
HTS_TST Service Delivery Point (Facility): Outpatient 2017 27,861
HTS_TST Service Delivery Point (Facility): Outpatient 2017 3,291
HTS_TST Service Delivery Point (Facility): Pediatric 2017 9,366
HTS_TST Service Delivery Point (Facility): Pediatric 2017 7,050
HTS_TST Service Delivery Point (Facility): PMTCT 2017 8,005
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 1,497
HTS_TST Service Delivery Point (Facility): VCT 2017 1,902
HTS_TST Service Delivery Point (Facility): VCT 2017 207
HTS_TST Sum of Age/Sex disaggregates 2017 5,660
HTS_TST Sum of Age/Sex disaggregates 2017 5,850
HTS_TST Sum of Aggregated Age/Sex <15 2017 11,017
HTS_TST Sum of Aggregated Age/Sex <15 2017 8,859
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 53,429
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 49,692
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 64,446
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 58,551
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 15
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 8
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 5
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 6
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 109
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 42
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 79
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 43
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 46
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 84
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 34
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 80
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 131
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 106
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 95
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 102
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 29
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 18
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 21
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 15
HTS_TST_POS Test Result by Age: Positive: <1 2017 13
HTS_TST_POS Test Result by Age: Positive: <1 2017 8
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 52
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 49
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 464
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 451
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 411
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 408
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 2,580
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 2,215
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 2,173
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 2,058
PMTCT_ART Already on ART at beginning of current pregnancy 2017 949
PMTCT_ART New on ART 2017 632
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 8,326
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 1,266
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 315
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 40
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 166
PMTCT_EID Sum of Infant Age disaggregates 2017 1,581
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 44
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 218
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 523
PMTCT_STAT By Age (DREAMS SNUs ONLY): 50+ 2017 86
PMTCT_STAT By: Known positives at entry 2017 1,169
PMTCT_STAT By: Number of new positives identified 2017 779
PMTCT_STAT Number of new ANC and L&D clients 2017 8,764
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 8,326
PMTCT_STAT Required only for DREAMS countries - By known positives: 15-19 2017 26
PMTCT_STAT Required only for DREAMS countries - By known positives: 20-24 2017 131
PMTCT_STAT Required only for DREAMS countries - By known positives: 25-49 2017 366
PMTCT_STAT Required only for DREAMS countries - By new positives: 15-19 2017 17
PMTCT_STAT Required only for DREAMS countries - By new positives: 20-24 2017 87
PMTCT_STAT Required only for DREAMS countries - By new positives: 25-49 2017 244
PMTCT_STAT Sum of Positives Status disaggregates 2017 1,948
PMTCT_STAT_den Required only for DREAMS countries - Denominator: 15-19 2017 46
PMTCT_STAT_den Required only for DREAMS countries - Denominator: 20-24 2017 229
PMTCT_STAT_den Required only for DREAMS countries - Denominator: 25-49 2017 550
PMTCT_STAT_den Required only for DREAMS countries - Denominator: 50+ 2017 92
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 28
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 189
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 27
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 175
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 524
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 419
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 2,765
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Other (Not Xpert) 2017 10
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Smear Only 2017 2,206
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 575
TB_SCREENDX Screen Results: Screened Positive for TB 2017 3,045
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 2,319
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 2,217
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 14,295
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 13,872
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 32,703
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 54
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 333
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 53
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 312
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 752
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 767
TX_CURR Age/Sex: <1 2017 495
TX_CURR Age/Sex: <1 2017 124
TX_CURR Age/Sex: <1-9 2017 486
TX_CURR Age/Sex: 1-9 2017 1,973
TX_CURR Age/Sex: 10-14 Female 2017 505
TX_CURR Age/Sex: 10-14 Female 2017 126
TX_CURR Age/Sex: 10-14 Male 2017 482
TX_CURR Age/Sex: 10-14 Male 2017 121
TX_CURR Age/Sex: 15-19 Female 2017 1,460
TX_CURR Age/Sex: 15-19 Female 2017 359
TX_CURR Age/Sex: 15-19 Male 2017 1,501
TX_CURR Age/Sex: 15-19 Male 2017 386
TX_CURR Age/Sex: 20-24 Female 2017 3,625
TX_CURR Age/Sex: 20-24 Female 2017 910
TX_CURR Age/Sex: 20-24 Male 2017 3,780
TX_CURR Age/Sex: 20-24 Male 2017 926
TX_CURR Age/Sex: 25-49 Female 2017 4,330
TX_CURR Age/Sex: 25-49 Female 2017 1,098
TX_CURR Age/Sex: 25-49 Male 2017 4,556
TX_CURR Age/Sex: 25-49 Male 2017 1,105
TX_CURR Age/Sex: 50+ Female 2017 927
TX_CURR Age/Sex: 50+ Female 2017 241
TX_CURR Age/Sex: 50+ Male 2017 1,048
TX_CURR Age/Sex: 50+ Male 2017 240
TX_CURR Aggregated Age/Sex: <15 Female 2017 2,314
TX_CURR Aggregated Age/Sex: <15 Female 2017 438
TX_CURR Aggregated Age/Sex: <15 Male 2017 2,226
TX_CURR Aggregated Age/Sex: <15 Male 2017 419
TX_CURR Aggregated Age/Sex: 15+ Female 2017 13,744
TX_CURR Aggregated Age/Sex: 15+ Female 2017 2,608
TX_CURR Aggregated Age/Sex: 15+ Male 2017 14,152
TX_CURR Aggregated Age/Sex: 15+ Male 2017 2,657
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 32,436
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 6,122
TX_CURR Sum of age/sex disaggregates 2017 745
TX_CURR Sum of Age/Sex disaggregations 2017 2,961
TX_CURR Sum of Aggregated Age/Sex <15 2017 4,540
TX_CURR Sum of Aggregated Age/Sex <15 2017 857
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 27,896
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 5,265
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 32,436
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 6,122
TX_NEW Aggregated Grouping by Age: <1 2017 71
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 321
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 442
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 303
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 422
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 1,848
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 2,631
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 1,986
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 2,678
TX_NEW By Age/Sex: <1 2017 125
TX_NEW By Age/Sex: 1-9 2017 287
TX_NEW By Age/Sex: 1-9 2017 491
TX_NEW By Age/Sex: 10-14 Female 2017 76
TX_NEW By Age/Sex: 10-14 Female 2017 127
TX_NEW By Age/Sex: 10-14 Male 2017 70
TX_NEW By Age/Sex: 10-14 Male 2017 121
TX_NEW By Age/Sex: 15-19 Female 2017 204
TX_NEW By Age/Sex: 15-19 Female 2017 362
TX_NEW By Age/Sex: 15-19 Male 2017 222
TX_NEW By Age/Sex: 15-19 Male 2017 388
TX_NEW By Age/Sex: 20-24 Female 2017 510
TX_NEW By Age/Sex: 20-24 Female 2017 917
TX_NEW By Age/Sex: 20-24 Male 2017 539
TX_NEW By Age/Sex: 20-24 Male 2017 933
TX_NEW By Age/Sex: 25-49 Female 2017 627
TX_NEW By Age/Sex: 25-49 Female 2017 1,109
TX_NEW By Age/Sex: 25-49 Male 2017 721
TX_NEW By Age/Sex: 25-49 Male 2017 1,115
TX_NEW By Age/Sex: 50+ Female 2017 131
TX_NEW By Age/Sex: 50+ Female 2017 243
TX_NEW By Age/Sex: 50+ Male 2017 141
TX_NEW By Age/Sex: 50+ Male 2017 242
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 4,458
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 6,173
TX_NEW Sum of Age/Sex disaggregates 2017 3,241
TX_NEW Sum of Age/Sex disaggregates 2017 5,557
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 4,458
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 6,173
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 7,244
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 5,072
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 358
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 348
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 2,227
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 2,139
TX_PVLS Numerator: Indication: Routine 2017 3,902
TX_PVLS Numerator: Indication: Targeted 2017 1,170
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 515
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 496
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 3,179
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 3,054
TX_PVLS_den Denominator: Indication: Routine 2017 5,572
TX_PVLS_den Denominator: Indication: Targeted 2017 1,672
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 14
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 10
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 10
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 26
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 25
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 31
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 30
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 7
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 5
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 366
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 352
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,252
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,165
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 5,135
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 5,551
TX_RET_den Age/Sex: <1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 4
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 14
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 4
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 4
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 11
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 11
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 28
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 27
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 33
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 32
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 7
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 6
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 396
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 381
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,435
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,339
Cross Cutting Budget Categories and Known Amounts Total: $167,996
Human Resources for Health $100,799
Gender: Gender Equality $67,197
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research